PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 88 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $301,000 | +42.0% | 31,866 | -14.1% | 0.02% | +15.4% |
| Q3 2015 | $212,000 | -55.6% | 37,114 | -53.5% | 0.01% | -55.2% |
| Q1 2015 | $478,000 | +208.4% | 79,863 | +290.7% | 0.03% | +123.1% |
| Q4 2014 | $155,000 | +134.8% | 20,443 | +66.3% | 0.01% | +44.4% |
| Q4 2013 | $66,000 | -44.5% | 12,296 | -48.2% | 0.01% | -59.1% |
| Q3 2013 | $119,000 | – | 23,730 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |